Guizhou Hu, MD, PhD
description
Transcript of Guizhou Hu, MD, PhD
Guizhou Hu, MD, PhDExecutive Vice President & Chief Scientific Officer BioSignia, Inc.
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Agenda
• What is Predictive Analytics?
• Predictive Analytics in life insurance
• An example of predictive model in life insurance underwriting
• Epidemiological research: the foundation of predictive models for life insurance underwriting
2
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Predictive Analytics: What is it?
According to the Society of Actuaries, predictive modeling is:
“A process used in predictive analytics to create a statistical model of future behavior. Predictive analytics is the area of data mining concerned with
forecasting probabilities and trends. A predictive model is made up of a number of predictors, variable factors that are likely to influence or predict future
behavior. The end result is both a set of factors that predict, to a relatively high degree, the outcome of an event, as well as what that outcome will be. In
marketing, for example, a customer’s gender, age and purchase history might predict the likelihood of a future sale. To create a predictive model, data is
collected for the relevant factors, a statistical model is formulated, predictions are made and the model is validated. The model may employ a simple linear
equation or can be a complex neural network or genetic algorithm.”
3
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Examples of Predictive Models
• LinkedIn connection recommendations• NCAA Tournament bracket tools• Amazon.com product recommendations• Framingham cardiovascular model
4
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Attributes of Good Predictive Models
5
• How was the model built?– Empirically(objective)-based or non-empirically
(subjective) based– Based on single dataset or multiple data.
• How was the model validated?– External and internal validation– Two statistical features measure prediction model
performance:
• Calibration: How close the prediction matches the observed outcomes among different risk groups
• Discrimination: How much the model differentiates risk between individuals who die and those who live
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Predictive Analytics in Life Insurance
• Target marketing• Fraud detection • Product design• Risk selection / underwriting
– Examples of predictive tools in underwriting:• Debit/credit scoring• Rules-engines• Financial credit scores (Deltoid)• MAT (BioSignia)• Lab scores (Exame One, CRL..)
6
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Industry Forces Shaping Adoption of Predictive Analytics
Industry Drivers
Data availability
Technological advances
Pressure for growth in slow markets
Availability of analytic talent
Pressure for competitive advantage
7
Industry Reservations
“black box” perception
Limited validation
Competing internal priorities
Lack of IT resources
Regulatory concerns
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Example of Predictive Analytics in life Insurance Underwriting
Mortality Assessment Technology (MAT)• How MAT was developed?
– Techniques
• Meta Analysis: summary of medical literature• Synthesis Analysis: integrate the multiple risk
factor into multivariate prediction equation.
– Contents: Primarily based on epidemiological research in medical fields
8
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
How MAT Was Validated
9
• Data set– ~311,000 historically issued policies– Up to 9 years death claims– Apply MAT along with conventional underwriting guidelines to the
underwriting data• Specific questions:
– Does the predicted mortality from MAT closely match the observed mortality? (calibration)
– Does the risk class defined by MAT have greater mortality differentiation than conventional underwriting? (discrimination)
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Validation Results
10
Conventional Classes
Class % PAE A/E
1 39% 0.5175 0.5299
2 30% 0.6302 0.6267
3 21% 0.7254 0.6767
4 10% 0.8609 0.8516
MAT output as predicted mortality
• Predicted mortality closely matches observed mortality• Conventional classification differentiates mortality by range
of 0.53-0.85
PAE
A/E Actual mortality expressed as A/E ratio of 2001 VBT
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Validation Results
11
MAT ClassesClass % PAE A/E
1 39% 0.4766 0.46782 30% 0.6084 0.58633 21% 0.7605 0.78084 10% 1.0125 0.9130
• Once again, predicted mortality closely matches observed mortality
• MAT differentiates mortality more than Conventional– MAT range (0.47-0.91)– Conventional range (0.52-0.85)
• MAT-defined best class has mortality 10% lower than conventionally-defined best class
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Epidemiological Research
12
• Epidemiological research is the foundation of predication analytics for life insurance underwriting
• Selected epidemiology studies carried out by scientists at BioSignia– Predicting mortality by:
• Clinical lab tests
• Cognitive function tests
• Social factors
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Clinical Lab Tests and Mortality
13
• Study population
– NHANES III: 4,610 deaths occurred during the 240,428 person-year study period
– Life insurance data: 837 death claims in 1.4 million person-year study period
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
AST and Mortality
14
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
ALT and Mortality
15
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
GGT and Mortality
16
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Blood Total Bilirubin and Mortality
17
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Alkaline Phosphatase and Mortality
18
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
BUN and Mortality
19
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Blood Creatinine and Mortality
20
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Blood Albumin and Mortality
21
NHANES III
Life Insurance
Good Predictor?
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Cognitive Function Tests and Mortality
22
• Study Population: Health Retirement Study (HRS)– 8,268 deaths occurred– 245,000 person-year study period
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Word Recall
23
• The interviewer read a list of 10 nouns (e.g., lake, car, army, etc.) to the respondent, and asked the respondent to recall as many words as possible from the list in any order.
% of individuals with score of <=4, by age and gender
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Series 7
24
• The interviewer asked the respondent to subtract 7 from 100, and continue subtracting 7 from each subsequent number for a total of five trials.
% of individuals with score of <=2 by age and gender
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Age, Gender and Smoking-adjusted Hazard Ratios of WR by Age Group in HRS
25
Age<60 Age 60-69
Age 70-79 Age >=80
Lower WR score, higher mortality. Impact decreases as age increases
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Age, Gender, and Smoking-adjusted Hazard Ratios of SER7 by Age Group in HRS
26
Age<60 Age 60-69
Age 70-79 Age >=80
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Social Factors and Mortality
27
• Study Population: NHANES III– 5,408 deaths occurred – 280,000 person-years study period
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Education and Mortality
28
• Hazard ratios of education level in age- and gender-adjusted Cox model, on all-cause mortality
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Employment and Mortality
29
• Hazard ratios for employment
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Marital Status and Future Mortality
30
• Hazard ratio for marital status
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Close with Friends and Family
31
• “How often do you get together with friends or relatives; I mean things like going out together or visiting in each other’s homes?”
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Socialization with Neighbors
32
• “How often do you visit with any of your other neighbors, either in their homes or in your own?”
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Church Attendance
33
• “How often do you attend church or religious services?”
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Belong to any Social Organization
34
• “Do you belong to any clubs or organizations such as church groups unions, fraternal or athletic groups, or school groups?”
© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.
Summary
35
• Predictive analytics
– Broad fields with various applications
– Various models in the marketplace for life underwriting
• Validation of the model is difficult, but important
• Epidemiological research and literature support are the foundation of predictive analytics